<DOC>
	<DOCNO>NCT00155779</DOCNO>
	<brief_summary>The acute respiratory distress syndrome ( ARDS ) important cause acute respiratory failure high mortality rate . The mechanism resolution late organize phase remain uncertain . The ACE gene contains polymorphism base presence ( insertion , I ) absence ( deletion , D ) within intron 287-bp nonsense DNA domain , result three genotype ( DD II homozygotes , ID heterozygotes ) . It show I/D polymorphism ACE gene may account half variance serum ACE level Caucasians . Polymorphism ACE gene also show contribute development respiratory disease . We hypothesize presence ACE gene polymorphism affect outcome ARDS . The objective propose study determine genotype ACE gene polymorphism assess influence ACE genotype outcome pulmonary resolution patient ARDS . Patients diagnose ARDS eligible possible inclusion study . The ACE genotype patient ARDS determine polymerase chain reaction ( PCR ) amplification respective fragment D I alleles intron 16 ACE gene size fractionation electrophoresis . The outcome patient ARDS three genotype compare .</brief_summary>
	<brief_title>ACE Gene Polymorphism ARDS Outcome</brief_title>
	<detailed_description>Study Design . This observational study patient ARDS . The study review approve Institutional Review Board National Taiwan University Hospital . Patients admit medical ICU National Taiwan University Hospital screen eligibility . Patients consider eligible 18 year age fulfil American-European Consensus Committee criterion ARDS : ) acute onset ; b ) bilateral pulmonary infiltrates ; c ) severely impaired oxygenation , i.e. , PaO2/FIO2 &lt; 200 mmHg ; ) pulmonary artery occlusion pressure &lt; 18 mmHg evidence leave atrial hypertension ( 1 ) . Exclusion criterion : ) previous history ARDS ; b ) receive angiotensin-converting enzyme inhibitor angiotensin receptor antagonist within one month development ARDS ; c ) receive mechanical ventilation due chronic respiratory failure ; ) receive invasive mechanical ventilation occurrence ARDS . If patient repeat episode ARDS study period , first episode would study included analysis . The diagnosis sepsis base criterion American College Chest Physicians/Society Critical Care Medicine Consensus Conference Committee ( 21 ) . In addition , two control group , consist “ at-risk ” patient “ non-at-risk ” , respectively , recruit comparison . The patient “ at-risk ” group admit MICU due acute respiratory failure meet diagnostic criterion ARDS throughout hospital course . The “ non-at-risk ” group previous history respiratory failure admission ICU reason , hospitalize within 6 month inclusion . Clinical Data Collection Outcome . For ARDS at-risk group , follow data collect admission ICU : co-morbidities , Acute Physiology Chronic Health Evaluation ( APACHE II ) score ( 22 ) , gender , age , reason admission . For ARDS group , Lung Injury Scores ( LIS ) measure time diagnosis ARDS ( 23 ) . For at-risk group , high lung LIS ’ also record . During MICU admission , best PaO2/FIO2 mode mechanical ventilation record daily major organ function ( serum creatinine , blood cell platelet count , serum alanine aminotransferase ) regularly determine . Decisions specific supportive treatment ARDS ( prone positioning , inhale nitric oxide , high-frequency oscillation ventilation , etc . ) , wean extubation determine attend physician accord clinical condition test eligibility extubation . The primary outcome study survival 28th day ARDS onset . The secondary outcome survival hospital discharge . ACE Polymorphism . After informed consent obtain patient control subject , peripheral blood sample obtain enediaminetetraacetic acid ( EDTA ) add . Genomic DNA extract use commercial kit ( QIAamp DNA Blood Mini Kit , Qiagen , Valencia , CA ) accord manufacturer ’ instruction store -20˚C concentration 100 ng/L genotyping study . The ACE I/D genotype determine PCR amplification respective fragment D I alleles intron 16 ACE gene size fractionation electrophoresis previously describe elsewhere ( 24 ) . Standard PCR perform 20 pmol primer ( 5 ’ CTGGAGACCACTCCCATCCTTTCT3 ’ 5 ’ GATGTGGCCATCACATTCGTCAGAT3 ’ ) final volume 25 L , contain 1.5 mM MgCl2 , 50 mM KCl , 10 mM Tris-HCl pH 8.3 , 0.2 mM dNTP , 1.25 unit Taq polymerase ( Perkin Elmer-Cetus ; Norwalk , Conn ) . The DNA amplify 30 cycle denaturation 94˚C 30 , anneal 58˚C 30 , extension 72˚C 1 min , follow final extension 72˚C 5 min ( DNA Thermal Cycler 480 ; Perkin Elmer-Cetus ) . The PCR product electrophoresed 2 % agarose gel 5 g ethidium bromide/mL , identify 300-nm ultraviolet transillumination distinct band ( D allele : 191 bp ; I allele : 478 bp ) . Because concern mistyping ID DD , sample find DD genotype subject second , independent PCR amplification primer pair recognize insertion-specific sequence ( 5 ’ TGGGACCACAGCGCCCGCCACTAC ’ 3 5 ’ TCGCCAGCCCTCCCATGCCCATAA ’ 3 ) ( 25 ) . The PCR condition describe elsewhere ( 25 ) . The reaction yield 335-bp amplicon presence I allele , product sample homozygous DD . Statistical Analysis . The SPSS statistical package ( version 10.1 Windows ; SPSS , Chicago , IL ) use statistical analysis . Continuous data express mean  SD . Comparisons continuous data perform ANOVA two-sample test . The chi-square table use compare observed number genotype expect population Hardy-Weinberg equilibrium compare genotype frequency ARDS population control group . The 28-day survival survival hospital discharge genotype estimate Kaplan-Meier method , statistical significance test use log-rank test . Multivariate analyse primary secondary outcome perform Cox proportional hazard method . For test , p value 0.05 less consider significant .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<criteria>Patients acute respiratory distress syndrome require intensive care mechanical ventilation Pregnancy History previous acute respiratory distress syndrome Chronic respiratory failure ventilator use Receiving angiotensinconverting enzyme inhibitor angiotensin receptor blocker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>adult respiratory distress syndrome</keyword>
	<keyword>angiotensin-converting enzyme</keyword>
	<keyword>polymorphism</keyword>
</DOC>